Home › Breast Cancer › New Hampshire
Breast Cancer clinical trials in New Hampshire
16 studies for Breast Cancer are looking for participants at sites in New Hampshire.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Dana-Farber/New Hampshire Oncology-Hematology, Londonderry
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06377852Testing a Mammography Decision Intervention in a Rural Setting
- Cheshire Medical Center, Keene
- New London Hospital Primary Care, New London
- Newport Health Center, Newport
Recruiting
Ages 39 to 49 · Women · Updated Sep 24, 2026 · NCT06522568Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07085767A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07174336A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Dartmouth Hitchcock Medical, Lebanon
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Dartmouth Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors
- Dartmouth-Hitchcock Clinic, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07706556ATEMPT 2.0: Adjuvant T-DM1 vs TH
- NH Oncology-Hematology, PA - Payson Center for Cancer Care, Concord
- Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry
- Solinsky Center for Cancer Care (NH Oncology-Hematology, PA), Manchester
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04893109MRg-NIRS Imaging System Breast Cancer Trial
- Dartmouth-Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 to 83 · Women · Updated Jun 23, 2026 · NCT06400563A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
- Dartmouth-Hitchcock Clinic, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06258993STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 2
Ages 18 and older · Women · Updated May 5, 2026 · NCT05716516De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 3
Ages 50 to 70 · All sexes · Updated Apr 23, 2026 · NCT04852887Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT02926690Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
- Dartmouth Cancer Center, Lebanon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT07071038Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
- Dartmouth Cancer Center, Lebanon
RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 20, 2025 · NCT05900895From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.